Comparing Costs and Consequences of Eltrombopag Plus IST Versus IST Alone for First-Line Treatment in Severe Aplastic Anemia: Results from a Responder Analysis

Tremblay Gabriel; Said Qayyim; Cai Beilei; Garib Shan Ashton; Tomaras Dimitrios; Forsythe Anna; Roy Anuja

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Comparing Costs and Consequences of Eltrombopag Plus IST Versus IST Alone for First-Line Treatment in Severe Aplastic Anemia: Results from a Responder Analysis

【24h】

Comparing Costs and Consequences of Eltrombopag Plus IST Versus IST Alone for First-Line Treatment in Severe Aplastic Anemia: Results from a Responder Analysis

机译：比较Eltompag Plus IST与IST的成本和后果仅用于严重血栓性贫血中的一线治疗：响应者分析的结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
作者
Tremblay Gabriel; Said Qayyim; Cai Beilei; Garib Shan Ashton; Tomaras Dimitrios; Forsythe Anna; Roy Anuja;
展开▼
作者单位

Purple Squirrel Econ New York NY USA;

Novartis Pharmaceut E Hanover NJ USA;

Novartis Pharmaceut E Hanover NJ USA;

Purple Squirrel Econ New York NY USA;

Purple Squirrel Econ New York NY USA;

Purple Squirrel Econ New York NY USA;

Novartis Pharmaceut E Hanover NJ USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Comparing Costs and Consequences of Eltrombopag Plus IST Versus IST Alone for First-Line Treatment in Severe Aplastic Anemia: Results from a Responder Analysis [J] . Tremblay Gabriel, Said Qayyim, Cai Beilei, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：比较Eltompag Plus IST与IST的成本和后果仅用于严重血栓性贫血中的一线治疗：响应者分析的结果
2. Eltrombopag Rescue for Childhood Severe Acquired Aplastic Anemia after Poor Response to Immunosuppressive Treatment: A Nationwide Study on Behalf of the French Reference Center for Aplastic Anemia [J] . Buchbinder Nimrod, De latour Regis Peffault, De Fontbrune Flore Sicre, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：在免疫抑制治疗的反应不良后，为儿童严重获得的儿童严重获得的血栓性贫血的救援：全国性研究代表法国参考中心的血栓性贫血
3. Efficacy of porcine antihuman lymphocyte immunoglobulin compared to rabbit antithymocyte immunoglobulin as a first-line treatment against acquired severe aplastic anemia [J] . Liu Limin, Ding Li, Hao Lin, Annals of hematology . 2015,第5期

机译：猪抗人淋巴细胞免疫球蛋白与兔抗胸腺细胞免疫球蛋白相比作为治疗获得性严重再生障碍性贫血的一线治疗的疗效
4. Evaluation of Life-Cycle Costs and Cost/Benefit Analysis in Comparing Sewer Replacement versus Sewer Rehabilitation [C] . John Killips, Chad Gamble Collection Systems Conference . 2013

机译：下水道更换与下水道修复比较中的生命周期成本评估和成本/效益分析
5. A comprehensive costing analysis of intensive case management for individuals with severe mental illness and a history of homelessness, including cost-effectiveness as compared to standard care. [D] . Birnie, Sarah. 2009

机译：对严重精神疾病和无家可归史的患者进行强化病例管理的综合成本分析，包括与标准护理相比的成本效益。
6. Budget Impact Of Eltrombopag As First-Line Treatment For Severe Aplastic Anemia In The United States [O] . Gabriel Tremblay, Qayyim Said, Anuja Nidumolu Roy, 2019

机译：Eltrombopag作为美国严重再生障碍性贫血的一线治疗的预算影响
7. PRO99 MULTI-CRITERIA DECISION ANALYSIS (MCDA) OF ELTROMBOPAG OLAMINE IN THE TREATMENT OF PATIENTS WITH REFRACTORY SEVERE APLASTIC ANEMIA UNDER THE PRIVATE HEALTHCARE SYSTEM IN BRAZIL: A HEALTH TECHNOLOGY ASSESSMENT (HTA) ALTERNATIVE MODEL [O] . R.R. Nascimento Junior, M. Santos, H.S.J. Kim, 2019

机译：BRO99多标准决策分析（MCDA）在巴西私营医疗保健系统下治疗难治性严重血栓性贫血患者的患者：卫生技术评估（HTA）替代模型

Comparing Costs and Consequences of Eltrombopag Plus IST Versus IST Alone for First-Line Treatment in Severe Aplastic Anemia: Results from a Responder Analysis

著录项

相似文献

相关主题

期刊订阅